Vfend and blood alkaline phosphatase increased Patient Reports February 12, 2012

Vfend Side Effects Report #5061644-X
Vfend side effect was reported by a Physician from UNITED STATES on July 10, 2006. Female patient, 75 years of age, was diagnosed with systemic mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, haematocrit decreased, haemoglobin decreased, prothrombin time prolonged, red blood cell count decreased. Vfend dosage: unknown. During the same period patient was treated with ZYVOX. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5109490-2
Vfend side effect was reported by a Physician from JAPAN on Sept 06, 2006. Male patient, 77 years of age, was diagnosed with pulmonary mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, condition aggravated, decreased appetite, optic neuritis, pulmonary mycosis, white blood cell count decreased. Vfend dosage: 300 MG (150 MG, 2 IN 1 D), ORAL. During the same period patient was treated with GASTER D, LEVOFLOXACIN, CLARITHROMYCIN, PERDIPIN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5854442-8
Vfend side effect was reported by a Physician from JAPAN on Aug 12, 2008. Male patient, 75 years of age, was diagnosed with pulmonary mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, transaminases increased. Vfend dosage: DAILY DOSE:400MG. Patient was hospitalized. Patient died on 08/01/2008.

Vfend Side Effects Report #5863684-7
Vfend side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, weighting 99.21 lb, was diagnosed with pulmonary mycosis, fungal infection , bronchitis , diarrhoea, oedema, inflammation and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: unknown. During the same period patient was treated with URSO, FLOMOX, BIO THREE, ALBUMIN TANNATE, LASIX, PREDONINE. Patient was hospitalized. Patient died on 08/09/2008.


Vfend Side Effects Report #4939522-3
Vfend side effect was reported by a Physician from JAPAN on Feb 23, 2006. Male patient, 76 years of age, weighting 88.18 lb, was diagnosed with pneumonia aspergillus and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood potassium increased, cyanopsia, haemolysis, hepatic function abnormal, infection , refusal of treatment by patient. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with LIPITOR, ASPIRIN, MAGNESIUM OXIDE, SINGULAIR, ENALAPRIL MALEATE, MUCOBULIN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4823817-8
Vfend side effect was reported by a Pharmacist from JAPAN on Oct 27, 2005. Male patient was diagnosed with ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, pyrexia. Vfend dosage: unknown. Patient recovered.

Vfend Side Effects Report #4779458-4
Vfend side effect was reported by a Physician from UNITED STATES on Sept 13, 2005. Female patient, 57 years of age, weighting 90.00 lb, was diagnosed with fungal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, bone pain, gamma-glutamyltransferase increased, osteitis deformans. Vfend dosage: unknown. During the same period patient was treated with IMMUNOSUPPRESSIVE AGENTS. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5150400-X
Vfend side effect was reported by a Pharmacist from JAPAN on Oct 25, 2006. Male patient, 71 years of age, was diagnosed with eye infection fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ITRACONAZOLE. Patient recovered.

Vfend Side Effects Report #5167217-2
Vfend side effect was reported by a Physician from JAPAN on Nov 20, 2006. Male patient, 71 years of age, was diagnosed with eye infection fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ITRACONAZOLE. Patient recovered.


Vfend Side Effects Report #5044556-7
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain  and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia , respiratory disorder. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.

Vfend Side Effects Report #5045942-1
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain  and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, opportunistic infection. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.

Vfend Side Effects Report #5288916-8
Vfend side effect was reported by a Health Professional from FRANCE on Apr 02, 2007. Male patient, 56 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatosplenomegaly, jaundice , pyrexia. Vfend dosage: unknown. During the same period patient was treated with CYTARABINE, VANCOMYCIN, ESOMEPRAZOLE MAGNESIUM, DIHYDROERGOTAMINE MESYLATE, CIPROFLOXACIN, PIPERACILLIN, PARACETAMOL, RITUXIMAB. Patient died on 06/23/2006.

Vfend Side Effects Report #5717104-3
Vfend side effect was reported by a Physician from JAPAN on Apr 15, 2008. Female patient, weighting 105.8 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, ileus paralytic, muscular weakness. Vfend dosage: unknown. During the same period patient was treated with ONCOVIN, AMBISOME, TARGOCID, BIAPENEM, LANSOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Vfend Side Effects Report #5724354-9
Vfend side effect was reported by a Physician from JAPAN on Apr 22, 2008. Female patient, weighting 105.8 lb, was diagnosed with bronchopulmonary aspergillosis, acute lymphocytic leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, ileus paralytic, muscular weakness. Vfend dosage: unknown. During the same period patient was treated with ONCOVIN, AMBISOME, TARGOCID, BIAPENEM, LANSOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.


Vfend Side Effects Report #5131096-X
Vfend side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, 43 years of age, weighting 128.0 lb, was diagnosed with aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: arthralgia, blood alkaline phosphatase increased, body temperature increased, decreased appetite, inflammation. Vfend dosage: 800 MG (400 MG,2 IN 1 D),ORAL. During the same period patient was treated with PAXIL, PROTONIX, AMBIEN, LOPRESSOR, WARFARIN, FENTANYL. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5750134-4
Vfend side effect was reported by a Consumer or non-health professional from FRANCE on May 15, 2008. Male patient, 35 years of age, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: agitation, blood alkaline phosphatase increased, blood bilirubin increased, coma, confusional state, cytolytic hepatitis, gamma-glutamyltransferase increased, hypovolaemia. Vfend dosage: unknown. During the same period patient was treated with AZITHROMYCIN, PREDNISONE, SULFAMETHOXAZOLE, BROMAZEPAM. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4701784-5
Vfend side effect was reported by a Consumer or non-health professional from on June 14, 2005. Female patient, child 11 years of age, weighting 97.00 lb, was diagnosed with aspergillosis, leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain , blood alkaline phosphatase increased, blood bilirubin increased, bronchopulmonary aspergillosis, flushing, headache . Vfend dosage: 200 MG (100 MG 2 IN 1 D) INTRAVENOUS; 300 MG (150 MG 2 IN 1 D INTRAVENOUS). During the same period patient was treated with ASPARGINASE, MERCAPTOPURINE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5711728-5
Vfend side effect was reported by a Pharmacist from AUSTRALIA on Apr 09, 2008. Male patient, weighting 176.4 lb, was diagnosed with antifungal prophylaxis, evidence based treatment, pneumocystis jiroveci pneumonia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anion gap increased, blood albumin decreased, blood alkaline phosphatase increased, blood bicarbonate increased, blood bilirubin increased, blood calcium decreased, blood creatine phosphokinase decreased, blood creatinine increased. Vfend dosage: unknown. During the same period patient was treated with BACTRIM, VINCRISTINE, PREDNISOLONE. Patient recovered.

Vfend Side Effects Report #5146288-3
Vfend side effect was reported by a Physician from JAPAN on Oct 19, 2006. Male patient, 87 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, interstitial lung disease. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, IMMUNOSUPPRESSIVE AGENTS. Patient died on 10/01/2006.